FDA's Overreach on Compounded Peptides Nasal tanning sprays linked to skin cancer, trading standards officers warn Consumer affairs The Guardian Melanotan II in Santa Barbara, CA Eternity Health Partners In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Emerging Threat: Melanotan, Repackaging, and Online Sales Illegal tanning nasal spray not a 'harmless alternative' to sunbaking, says TGA ABC News